20.71
2.04 (10.93%)
| 前收盘价格 | 18.67 |
| 收盘价格 | 18.41 |
| 成交量 | 1,731,828 |
| 平均成交量 (3个月) | 980,114 |
| 市值 | 1,749,568,640 |
| 价格/销量 (P/S) | 38.01 |
| 股市价格/股市净资产 (P/B) | 3.02 |
| 52周波幅 | |
| 利润日期 | 6 Aug 2026 |
| 营业毛利率 | 3.86% |
| 营业利益率 (TTM) | 51.85% |
| 稀释每股收益 (EPS TTM) | 0.120 |
| 季度收入增长率 (YOY) | 7,882.00% |
| 总债务/股东权益 (D/E MRQ) | 15.21% |
| 流动比率 (MRQ) | 5.61 |
| 营业现金流 (OCF TTM) | 34.67 M |
| 杠杆自由现金流 (LFCF TTM) | 40.54 M |
| 资产报酬率 (ROA TTM) | -0.40% |
| 股东权益报酬率 (ROE TTM) | 2.88% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | Monte Rosa Therapeutics, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
| 分析师共识 | 2.0 |
| 内部交易活动 | -3.0 |
| 价格波动 | -1.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.0 |
| 平均 | -0.10 |
|
Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 0.73% |
| 机构持股比例 | 101.33% |
该时间范围内无数据。
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| CHAMPOUX JENNIFER | - | 18.41 | -2,176 | -40,060 |
| TOWNSON SHARON | - | 18.41 | -3,000 | -55,230 |
| 累积净数量 | -5,176 | |||
| 累积净值 ($) | -95,290 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 18.41 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| TOWNSON SHARON | 职员 | 17 Jun 2026 | 自动卖出 (-) | 3,000 | 18.41 | 55,230 |
| TOWNSON SHARON | 职员 | 17 Jun 2026 | 执行期权 | 3,000 | - | - |
| CHAMPOUX JENNIFER | 职员 | 17 Jun 2026 | 自动卖出 (-) | 2,176 | 18.41 | 40,060 |
| CHAMPOUX JENNIFER | 职员 | 17 Jun 2026 | 执行期权 | 2,176 | - | - |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合